Vaxart
Latest round
- Series C
Last raised
- Aug 2013
Total raised
- $39M
Investors
- 5
About Vaxart
Vaxart, Inc. is a biotechnology company focused on developing oral recombinant vaccines aimed at providing immunity against various viral diseases.Vaxart, Inc. specializes in the development of oral vaccines. Founded in 2004, the company is headquartered in San Francisco, US.40 mn.Vaxart focuses on oral recombinant pill vaccines that aim to provide mucosal and systemic immunity against viral diseases. Their technology creates vaccines targeting COVID-19, norovirus, influenza, and human papillomavirus (HPV).Vaxart plans to expand its product offerings with new oral vaccines that are currently in development, targeting launch by 2025. The company aims to enter new geographical markets in North America and Europe by this date as well.
Who invested in Vaxart
5 investors across 4 rounds
See all investors in Vaxart
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vaxart
Who invested in Vaxart?
Vaxart has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaxart raised?
Vaxart has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vaxart last raise money?
Vaxart's most recent round on record is a Series C, in Aug 2013.
What does Vaxart do?
Vaxart is a pharmaceuticals company.
Where is Vaxart headquartered?
Vaxart is headquartered in San Francisco, US.
Which VCs invest in companies like Vaxart?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vaxart's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Vaxart? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.